Replies to post #94274 on Biotech Values

[turtlepower]

IDIX - When the first patient is dosed on 899 IDIX should receive about a quarters worth of cash right? Right now looks like a good time to raise cash with less dilution but maybe the new data is compelling enough for someone to sign a deal quickly.

[DewDiligence]

IDIX: Thomas Weisel increased price target to $9 (from $6), according to theflyonthewall.com (http://www.theflyonthewall.com/permalinks/entry.php/IDIXid1231193/Idenix-target-raised-to- ).

I’ll post info from the actual report when I see it, if someone else has not already done so.

Using the same kind of valuation arithmetic as in #msg-49053469, a $9 share price corresponds to an enterprise value of about $600M.